Boehringer launches at long-end of Schuldschein mart

Boehringer Ingelheim, the German pharmaceutical group, has decided to tap the long end of the Schuldschein market by launching a 10 year deal. The note is understood to be the first of that tenor in 2009 and is clear sign of the market’s recovery, according to bankers.

  • 11 Jun 2009

Boehringer, which is unrated but considered to be a double-A credit, launched its Eu300m five, seven and ten year facility towards the end of last week. Respective guidance on the tranches is 190bp-215bp, 235bp-260bp and 280bp-310bp.

The deal is being led by Helaba, HSBC and LBBW.

Bankers in Germany said ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 1,284 2 30.09
2 Barclays 633 1 14.82
3 BNP Paribas 509 1 11.91
4 Citi 467 1 10.94
5 Morgan Stanley 455 1 10.66

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 10,727.09 36 12.76%
2 Barclays 8,051.97 24 9.58%
3 Bank of America Merrill Lynch 7,814.11 25 9.30%
4 JPMorgan 7,477.76 27 8.90%
5 Wells Fargo Securities 6,648.29 26 7.91%